Prevalence of Toxoplasma encephalitis in AIDS patients treated with didanosine hospitalised in a French infectious service

Current HIV Research

Volumn 2, Issue 4, 2004, Pages 301-307

  Sarciron, Marie Elisabeth ^a   Ghérardi, Arnaud ^a   Delorme, Chantal ^a   Peyramond, Dominique ^a   Pétavy, Anne Françoise ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

AIDS; Didanosine; Opportunistic infection; Toxoplasma encephalitis; Treatment

Indexed keywords

ANTIRETROVIRUS AGENT; CLINDAMYCIN; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; PYRIMETHAMINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; BRAIN CYST; CONTROLLED STUDY; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PARASITE VIRULENCE; PRESCRIPTION; PREVALENCE; RELAPSE; REVIEW; TOXOPLASMA GONDII;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; COHORT STUDIES; DIDANOSINE; DRUG THERAPY, COMBINATION; ENCEPHALITIS; FEMALE; FRANCE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; TOXOPLASMOSIS, CEREBRAL;

EID: 4544283160     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162043351101     Document Type: Review

References (90)

1. [No authors listed] (2001). FDA Consum. 35:6.
2. Ali SM, Aliam SR, Negm AY, El Zawawy LA. (2003). Journal of the Egyptian Society of Parasitology. 33: 863-874.
3. Alvarez F, Ghérardi A, Nebois P, Sarciron ME, Pétavy AF, Walchshofer N. (2002). Bioorganic and Medicinal Chemistry Letters. 12: 977-979.
4. Ammassari A, Scoppettuolo G, Murri R, Pezzotti P, Cingolani A, Dei Borgo C, De Luca A, Antinori A, Ortona L. (1998). Journal of Acquired Immune Deficiency Syndromes. 18: 365-371.
5. Baggish AL, Hill DR. (2002). Antimicrobial Agents and Chemotherapy. 46: 1163-1173.
6. Beck EJ, Madalia S, Williams I, Power A, Newson R, Molesworth A, Barlow D, Easterbrook P, Fisher M, Innes J, Kinghorn G, Mandel B, Pozniak A, Tang A, Tomlinson D. (1999). AIDS. 13: 2157-2164.
7. Belanger F, Derouin F, Grangeot-Keros L, Meyer L. (1999). Clinical and Infectious Diseases. 28: 575-581.
8. Berenguer J, Laguna F, Lopez-Aldeguer J, Moreno S, Arribas JR, Arrizabalaga J, Baraia J, Casado JL, Cosin J, Polo R, Gonzalez-Garcia J, Iribarren JA, Kindelan JM, Lopez-Bernaldo de Quiros JC, Lopez-Velez R, Lorenzo JF, Lozano F, Mallolas J, Miro JM, Pulido F, Ribera E. (2004). Enfermedades infecciosas y microbiologia clinica. 22: 160-176.
9. Bhopale GM. (2003). Microbes and Infection. 5: 457-462
10. Bouaziz Z, Ghérardi A, Régnier F, Sarciron ME, Bertheau X, Fenet B, Walchshofer N, Fillion H. (2002). European Journal of Organic Chemistry. 1834-1838.
11. Bouhnik AD, Chesney M, Carrieri P, Gallais H, Moreau J, Moatti JP, Obadia Y, Spire B; MANIF 2000 Study Group. (2002). Journal of acquired immune deficiency syndromes. 31 Suppl 3:S149-53.
12. Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, Copas A, Boshoff C. (2004). AIDS. 18: 485-493.
13. Buchbinder SP, Holmberg SD, Scheer S, Colfax G, O'Malley P, Vittinghoff E. (1999). Journal of acquired immune deficiency syndromes. 21 Suppl. 1:S23-26.
14. Bucher HC, Griffith L, Guyatt GH, Opravil M. (1997). Journal of acquired immune deficiency syndromes and human retrovirology. 15:104-114.
15. Carr A, Tindall B, Brew BJ, Marriott DJ, Harkness JL, Penny R, Cooper DA. (1992) Annals of Internal Medicine 117:106-111.
16. Carrieri MP, Chesney MA, Spire B, Loundou A, Sobel A, Lepeu G, Moatti JP; MANIF Study Group. (2003). International journal of behavioral medicine. 10: 1-14.
17. Chen RY, Westfall AO, Mugavero MJ, Cloud GA, Raper JL, Chatham AG, Acosta EP, Taylor KH, Carter J, Saag MS. (2003). Clinical Infectious Disease 37: 714-722
18. Chesney M. (2003). AIDS Patient Care and STDS. 17: 169-177.
19. Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, Roque C, Rajicic N, McAuliffe V, Morlat P, Jayaweera DT, Vilde JL, Luft BJ. (2002). Clinical and Infectious Diseases. 34: 1243-1250.
20. Collazos J. (2003) Central Nervous System Drugs. 17: 869-887.
21. Dannemann B, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B, Nussbaum J, Clumeck N, Morlat P, Chiu J, et al. (1992). Annals of Internal Medicine. 116: 33-43.
22. D'Aquila R, Walker B. (1999). Journal of the American Medical Association. 282: 1668-1669.
23. Degerli K, Kilimcioglu AA, Kurt O, Tamay AT, Ozbilgin A. (2003). Acta Tropica. 88: 45-50.
24. Djurkovic-Djakovic O, Milenkovic V, Nikolic A, Bobic B, Grujic (2002). The Journal of antimicrobial chemotherapy. 50: 981-987.
25. Edlin BR. (1999). Lancet. 353: 1888.
26. Ena J, Pasquau F. (2003). Clinical and Infectious Disease. 36: 1186-1190.
27. Ena J, Pasquau F. (2003). Once-a-day highly active antiretroviral therapy: a systematic review. Clinical Infectious Diseases. 36: 1186-1190.
28. Fleischer R, Boxwell D, Sherman KE. (2004). Clinical and Infectious Disease. 38: e79-80.
29. Francis P, Patel VB, Bill PL, Bhigjee AI. (2004). South African Medicinal Journal. 94: 51-53.
30. Fung HB, Kirschenbaum HL. (1996). Clinical Therapeutics. 18: 1037-1056.
31. Furrer H and the Swiss HIV Cohort Study. (2002). Current Infectious Disease Reports. 4: 161-174.
32. Gangjee A, Adair OO, Queener SF. (2003). Journal of Medicinal Chemistry. 46: 5074-5082.
33. Gherardi A, Sarciron ME, Peyron F. (2000). Parasite. 7: 39-42.
34. Gray F, Chretien F, Vallat-Decouvelaere AV, Scaravilli F. (2003). Journal of neuropathology and experimental neurology. 62: 429-440.
35. Guarinieri M; ICoNA Community Advisory Board. (2002). Journal of acquired immune deficiency syndromes. 31 Suppl. 3:S167-169.
36. Guex AC, Radziwill AJ, Bucher HC. (2000). Clinical and Infectious Disease. 30: 602-3.
37. Happe S, Fischer A, Heese CH, Reichelt D, Gruneberg U, Freund M, Kloska S, Evers S, Husstedt IW. (2002). Der Nervenarzt. 73: 1174-1178.
38. Hermsen ED, Wynn HE, McNabb J. (2004). American journal of health-system pharmacy. 61: 245-256.
39. Hill D, Dubey JP. (2002) Clinical Microbiology and Infection. 8: 634-640.
40. Hirsch HH, Kaufmann G, Sendi P, Battegay M. (2004). Clinical and Infectious Disease. 38: 1159-1166
41. Jacobson JM, Hafner R, Remington J, Farthing C, Holden-Wiltse J, Bosler EM, Harris C, Jayaweera DT, Roque C, Luft BJ; ACTG 156 Study Team. (2001). AIDS. 15: 583-589.
42. Jones JL, Hanson DL, Chu SY, Ciesielski CA, Kaplan JE, Ward JW, Navin TR. (1996). AIDS. 10: 1393-1399.
43. Jones-Brando L, Torrey EF, Yolken R. (2003). Schizophrenia Research. 62: 237-244.
44. Kay-Thwe-Han, Rai-Mra, Htin-Aung-Saw, Ye-Htut, Wynn-Naing. (2003). The Southeast Asian journal of tropical medicine and public health, 34: 577-579.
45. Kazanjian PH, Fisk D, Armstrong W, Shulin Q, Liwei H, Ke Z, Meshnick S. (2004). Journal of Infectious Diseases. 189: 1684-1687.
46. Kirk O, Lundgren JD, Pedersen C, Nielsen H, Gerstoft J. (1999). AIDS. 13: 1647-1651.
47. Klein MB, Campeol N,Lalonde RG, Brenner B, Wainberg MA. (2003). AIDS. 17: 1001-1008.
48. Knobel H, Vallecillo G, Guelar A, Pedrol E, Soler A, Carmona A, Saballs P, Gonzalez A, Gimeno JL, Colomes JL. (2004). HIV Clinical Trials. 5: 65-73.
49. Laing RB, Flegg PJ, Brettle RP, Leen CL, Burns SM. (1996). International journal of STD & AIDS. 7: 258-264.
50. Landman R, Schiemann R, Thiam S, Vray M, Canestri A, Mboup S, Kane CT, Delaporte E, Sow PS, Faye MA, Gueye M, Peytavin G, Dalban C, Girard PM, Ndoye I; Imea 011/ANRS 12-04 Study Group. (2003). AIDS. 17:1017-1022.
51. Liesenfeld O, Wong SY, Remington JS. (1999). Toxoplasmosis in the Setting of AIDS. In: Merignan TC, Bartlett JG, Bolognesi D Eds, Textbook of AIDS Medicine. Baltimore, Williams & Wilkins. pp. 225-259.
52. Lopez S, Mito O, Martinez E, Pedrol E, Rodriguez-Santiago B, Milinkovic A, Soler A, Garcia-Viejo MA, Nunes V, Casademont J, Gatell JM, Cardellach F. (2004). Antiviral Therapy. 9: 47-55.
53. Malcolm SE, Ng JJ, Rosen RK, Stone VE. (2003). AIDS Care. 15: 251-261.
54. Masur H, Kaplan JE, Holmes KK; U.S. Public Health Service; Infectious Diseases Society of America (2002). Annals of Internal Medicine. 137:435-478.
55. Mitchell SM, Zajac AM, Davis WL, Lindsay DS. (2003). Journal of Eukaryotic Microbiology. 50 Suppl: 689-690.
56. Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H, Deayton J, Dykhoff A, Lipman MC, Phillips AN, Johnson MA. (1999). Journal of Acquired Immune Deficiency Syndromes. 21: 401-407.
57. Molina JM, Peytavin G, Perusat S, Lascoux-Combes C, Sereni D, Rozenbaum W, Chene G. (2004). HIV Medicine. 5: 99-104.
58. Montessori V, Press N, Harris M, Akagi L, Montaner JS. (2004). Canadian Medical Association Journal. 170: 229-238.
59. Moreno A, Quereda C, Moreno L, Perez-Elias MJ, Muriel A, Casado JL, Antela A, Dronda F, Navas E, Barcena R, Moreno S. (2004). Antiviral Therapy. 9: 133-138.
60. Mussini C, Pezzotti P, Miro JM, Martinez E, de Quiros JC, Cinque P, Borghi V, Bedini A, Domingo P, Cahn P, Bossi P, de Luca A, d'Arminio Monforte A, Nelson M, Nwokolo N, Helou S, Negroni R, Jacchetti G, Antinori S, Lazzarin A, Cossarizza A, Esposito R, Antinori A, Aberg JA; International Working Group on Cryptococcosis. (2004). Clinical and Infectious Disease. 38: 565-571.
61. Nath A, Sinal AP. (2003). Current Treatment Options in Neurology. 5: 3-12.
62. Nobre V, Braga E, Rayes A, Serufo JC, Godoy P, Nunes N, Antunes CM, Lambertucci JR. (2003). Revista do Instituto de Medicina Tropical de Sao Paulo. 45: 69-74.
63. Paul S, Gilbert HM, Lande L, Vaamonde CM, Jacobs J, Malak S, Sepkowitz KA. (2002). AIDS Res Hum Retroviruses. 18: 501-506.
64. Podzamczer D, Salazar A, Jimenez J, Consiglio E, Santin M, Casanova A, Rufi G, Gudiol F. (1995). Annals of Internal Medicine. 122: 755-761.
65. Press N, Tyndall MW, Wood E, Hogg RS, Montaner JS. (2002). Journal of Acquired Immune Deficiency Syndromes. 31 Suppl. 3: S112-117.
66. Rapp RP. (2004). Pharmacotherapy. 24: 4S-28S
67. Reijers MH, Weverling GJ, Juriaans S, Wit FW, Weigel HM, Ten Kate RW, Mulder JW, Frissen PH, Van Leeuwen R, Reiss. P, Schuitemaker H, De Wolf F, Lange JM. (1998). Lancet. 352: 185-190.
68. Roberts CW, McLeod R, Rice DW, Ginger M, Chance ML, Goad LJ. (2003). Molecular and Biochemical Parasitology. 126: 129-142.
69. Rosowsky A, Forsch RA, Queener SF. (2003). Journal of Medicinal Chemistry. 46: 1726-1736.
70. Rosowsky A, Forsch RA, Sibley CH, Inderlied CB, Queener SF. (2004). Journal of Medicinal Chemistry. 47: 1475-1486.
71. Rosowsky A, Fu H, Chan DC, Queener SF. (2004). Journal of Medicinal Chemistry. 47: 2475-2485.
72. Rutherford GW, Sangani PR, Kennedy GE. (2003). Cochrane Database of Systematic Reviews (4): CD002037.
73. Saba J, Morlat P, Raffi F, Hazebroucq V, Joly V, Leport C, Vilde JL. (1993). European Journal Of Clinical Microbiology & Infectious Diseases. 12: 853-856.
74. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC, Multicenter AIDS Cohort Study. (2001). Neurology. 56: 257-260.
75. San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, Costa JR, del Palacio A. (2003). Clinical Infectious Diseases. 36:1177-1185.
76. Sarciron ME, Lawton P, Petavy AF, Peyron F. (1998). Journal of Parasitology. 84: 1055-1059.
77. Sarciron ME, Lawton P, Saccharin C., Petavy AF, Peyron F. (1997). Antimicrobial Agents and Chemotherapy. 41: 1531-1536.
78. Schurmann D, Bergmann F, Albrecht H, Padberg J, Wunsche T, Grunewald T, Schurmann M, Grobusch M, Vallee M, Ruf B, Suttorp N. (2000) European Journal of Clinical Microbiology and Infectious Diseases. 21: 353-361.
79. Sheng WH, Hsieh SM, Lee SC, Chen MY, Wang JT, Hung CC, Chang SC. (2004). International Journal of STD and AIDS. 15:249-253.
80. Soriano V, Dona C, Rodriguez-Rosado R, Barreiro P, Gonzalez-Lahoz J. (2000). AIDS. 14: 383-386.
81. Sriram D, Yogeeswari P. (2003). Current Medicinal Chemistry. 10: 1689-95.
82. Tapia RA, Prieto Y, Pautet F, Walchshofer N, Fillion H, Fenet B, Sarciron ME. (2003). Bioorganic and Medicinal Chemistry. 11(16):3407-3412.
83. Tsai HC, Lee SS, Lin HH, Lin WR, Chen YS, Huang CK, Liu YC, Chen ER. (2002). Journal of the Formosan Medical Association. 101: 646-649.
84. Van Delden C, Gabriel V, Sudre P, Flepp M, Von Overbeck J, Hirshel B. (1996). AIDS. 10: 509-513.
85. Walker UA. (2003). Journal of HIV Therapy. 8: 32-35.
86. Weiss L, French T, Finkelstein R, Waters M, Mukherjee R, Agins B. (2003). AIDS Care. 15: 673-679.
87. Wiselka MJ, Read R, Finch RG. (1996). The Journal of Infection. 33: 227-229.
88. Wynn GH, Zapor MJ, Smith BH, Wortmann G, Oesterheld JR, Armstrong SC, Cozza KL. (2004). Psychosomatics. 45: 262-270.
89. Yadav V, Chu CK, Rais RH, Al Safarjalani ON, Guarcello V, Naguib FN, el Kouni MH. (2004). Journal of Medicinal Chemistry. 47: 1987-1996.
90. Zeller V, Truffot C, Agher R, Bossi P, Tubiana R, Caumes E, Jouan M, Bricaire F, Katlama C. (2002). Clinical and Infectious Diseases. 34: 662-627.